VEGFA and melanoma: As shown in Table 3, fourteen overlapping targets (GSK3B, MAPK1, HSPA8, VEGFA, FGF2, MTOR, and so on) were considered potential targets for the treatment of melanoma with salidroside (Figure 1C).